Microglia in Rasmussen Encephalitis

Microglia in Rasmussen Encephalitis

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Microglia in Rasmussen Encephalitis</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Immune-Mediated</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Unilateral cortex</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Activated microglia</td>
</tr>
<tr>
<td class="label">Pathology</td>
<td>CD8+ T-cell mediated</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000129](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000129](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4042028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>Description</td>
</tr>
<tr>
<td class="label">Focal seizures</td>
<td>Epilepsia partialis continua (continuous focal motor seizures)</td>
</tr>
<tr>
<td class="label">Progressive hemiparesis</td>
<td>Unilateral weakness progressing over months to years</td>

Microglia in Rasmussen Encephalitis

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Microglia in Rasmussen Encephalitis</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Immune-Mediated</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Unilateral cortex</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Activated microglia</td>
</tr>
<tr>
<td class="label">Pathology</td>
<td>CD8+ T-cell mediated</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000129](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000129](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4042028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>Description</td>
</tr>
<tr>
<td class="label">Focal seizures</td>
<td>Epilepsia partialis continua (continuous focal motor seizures)</td>
</tr>
<tr>
<td class="label">Progressive hemiparesis</td>
<td>Unilateral weakness progressing over months to years</td>
</tr>
<tr>
<td class="label">Cognitive decline</td>
<td>Perisylvian involvement leads to intellectual disability</td>
</tr>
<tr>
<td class="label">Cortical atrophy</td>
<td>Progressive hemiatrophy visible on MRI</td>
</tr>
</table>

Rasmussen encephalitis is a rare, progressive, and severe inflammatory disease of the brain that typically affects one cerebral hemisphere, predominantly in children. Microglia play a central role in the immunopathogenesis of this condition, mediating both the inflammatory response and the cytotoxic mechanisms that lead to progressive neuronal loss and cortical atrophy[@varadkar2014].

Microglia are the resident immune cells of the central nervous system and serve as the primary mediators of neuroinflammation in Rasmussen encephalitis. Their activation and interactions with T-cells drive the characteristic progressive neurological decline seen in this condition[@bien2002].

Overview

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: microglial cell (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000129)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)
• [OBO Foundry (CL:0000129)](http://purl.obolibrary.org/obo/CL_0000129)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000129)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)
• [OBO Foundry (CL:0000129)](http://purl.obolibrary.org/obo/CL_0000129)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Microglia Function

• Immune Surveillance: Brain monitoring
• Antigen Presentation: T-cell activation
• Cytotoxicity: Direct killing

Role in Rasmussen Encephalitis

Immune Pathogenesis

Rasmussen encephalitis is an immune-mediated disease characterized by a focal inflammatory process that progressively destroys one cerebral hemisphere. The pathogenesis involves a complex interplay between microglia, CD8+ cytotoxic T-cells, and neurons[@granata2003].

CD8+ T-cell mediated cytotoxicity:

• CD8+ T-cells recognize neuronal antigens presented on MHC-I molecules
• Cytotoxic T-cells release granzyme and perforin leading to apoptotic neuronal death
• The attack predominantly targets pyramidal neurons in the affected cortex
• Microglia serve as antigen-presenting cells that activate the T-cell response

• Activated microglia express increased levels of MHC-I and MHC-II
• Microglia produce pro-inflammatory cytokines including IL-1β, TNF-α, and IL-6
• Chronically activated microglia create a self-perpetuating inflammatory cycle
• Microglial proliferation correlates with disease progression[@gupta2004]

Neuroimaging Correlates

• PET imaging shows increased microglial activation in the affected hemisphere
• TSPO binding is elevated in active inflammatory regions
• Longitudinal PET demonstrates progressive involvement correlating with clinical decline[@chen2012]

Clinical Features

Treatment Approaches

• Immunotherapy: Corticosteroids, IVIG, cyclophosphamide may slow progression
• Anti-epileptic drugs: Control seizures but do not halt disease progression
• Hemispherectomy: Surgical disconnection of affected hemisphere (only curative option)
• Emerging therapies: T-cell targeted treatments under investigation[@loring2020]

See Also

• [Microglia Neuroinflammation](/mechanisms/microglia-neuroinflammation)
• [TREM2](/proteins/trem2)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [Epilepsy](/diseases/epilepsy)
• [Seizures](/conditions/seizures)

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Phase-Separated Organelle Targeting](/hypothesis/h-ec731b7a) — <span style="color:#81c784;font-weight:600">0.72</span> · Target: G3BP1
• [Purinergic P2Y12 Inverse Agonist Therapy](/hypothesis/h-f99ce4ca) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: P2RY12
• [Complement C1q Mimetic Decoy Therapy](/hypothesis/h-1fe4ba9b) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: C1QA
• [Metabolic Circuit Breaker via Lipid Droplet Modulation](/hypothesis/h-3d993b5d) — <span style="color:#81c784;font-weight:600">0.66</span> · Target: PLIN2
• [Temporal Decoupling via Circadian Clock Reset](/hypothesis/h-019ad538) — <span style="color:#81c784;font-weight:600">0.65</span> · Target: CLOCK
• [Fractalkine Axis Amplification via CX3CR1 Positive Allosteric Modulators](/hypothesis/h-ba3a948a) — <span style="color:#81c784;font-weight:600">0.63</span> · Target: CX3CR1
• [Synthetic Biology Rewiring via Orthogonal Receptors](/hypothesis/h-e3506e5a) — <span style="color:#ffd54f;font-weight:600">0.59</span> · Target: CNO
• [Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics](/hypothesis/h-513a633f) — <span style="color:#ffd54f;font-weight:600">0.58</span> · Target: ANXA1

Related Analyses:

• [TREM2 agonism vs antagonism in DAM microglia](/analysis/SDA-2026-04-01-gap-001) &#x1f504;
• [Microglial subtypes in neurodegeneration — friend vs foe](/analysis/SDA-2026-04-02-gap-microglial-subtypes-20260402004119) &#x1f504;
• [TREM2 agonism vs antagonism in DAM microglia](/analysis/SDA-2026-04-02-gap-001) &#x1f504;
• [Microglia-astrocyte crosstalk amplification loops in neurodegeneration](/analysis/SDA-2026-04-01-gap-009) &#x1f504;
• [Synaptic pruning by microglia in early AD](/analysis/SDA-2026-04-01-gap-v2-691b42f1) &#x1f504;

Pathway Diagram

The following diagram shows the key molecular relationships involving Microglia in Rasmussen Encephalitis discovered through SciDEX knowledge graph analysis: